ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.730
+0.140 (8.81%)
At close: Oct 9, 2026, 4:00 PM EDT
1.731
+0.001 (0.03%)
After-hours: Oct 9, 2026, 7:37 PM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year. That makes ADC Therapeutics the 27,090th largest employer in the world and 3,427th in the United States.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$412,352
Profits / Employee
-$502,114
Market Cap
220.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 193 | -72 | -27.17% | 188 | 5 |
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| BioAge Labs | 62 |
| Journey Medical | 58 |
ADCT News
- 1 day ago - ADC Therapeutics announces comprehensive strategic financial restructuring - TheFly
- 1 day ago - ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements - PRNewsWire
- 18 days ago - These beaten-down stocks could bounce back in January, if history is any guide - Market Watch
- 4 weeks ago - ADC Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - ADC Therapeutics Slides: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Filings
- 5 weeks ago - ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - PRNewsWire
- 7 weeks ago - ADC Therapeutics price target lowered to $5 from $10 at Guggenheim - TheFly
- 7 weeks ago - ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year - TheFly